Currently out of the existing stock ratings of Jonathan Yong, 46 are a BUY (46.94%), 5 are a SELL (5.1%), 47 are a HOLD (47.96%).

Jonathan Yong

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Yong works at CREDIT SUISSE with a stock forecast success ratio of 54.75% fulfilled within 93.15 days on average.

Jonathan Yong’s has documented 219 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Financial Services, Consumer Defensive sectors.

Most recent stock forecast was given on PINC, Premier at 24-Aug-2023.

Wall Street Analyst Jonathan Yong

Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP) at 8/9/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.21 (7.53%) receiving and performance score of 75.27.

Average potential price target upside

of $53.83 (24.34%) on HCA (HCA HOLDINGS).
of $50.6 (14.25%) on MCK (MCKESSON).
of $43.03 (14.37%) on MOH (MOLINA HEALTHCARE).

OSCR Oscar Health AMED Amedisys CHNG Change Healthcare CVS CVS Health Corp GOCO GoHealth . HCA HCA Holdings LH Laboratory of America Holdings LHCG LHC Group MOH Molina Healthcare WBA Walgreens Boots Alliance THC Tenet Healthcare ACCD Accolade CI Cigna Corp CNC Centene Corp GDRX Goodrx Holdings HIMS Hims Hers Health HUM Humana MCK McKesson TDOC Teladoc DH Definitive Healthcare Corp AMN AMN Healthcare Services CLOV Clover Health Investments Corp CYH Community Health Systems EHAB Enhabit . EHTH eHealth HSIC Henry Schein OMI Owens & Minor PRVA Privia Health Group CAH Cardinal Health EHC Encompass Health Corp HCSG Healthcare Services Group PDCO Patterson Companies PINC Premier SEM Select Medical Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Nathan Rich (GOLDMAN SACHS)